Gotham Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Gotham Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,636	Closed	-$539K	–	1252
2019 Q4	$539K	Buy	+13,636	New	+$239K	0.01%	793
2018 Q3	–	Sell	-11,717	Closed	-$154K	–	1048
2018 Q2	$154K	Buy	+11,717	New	+$140K	﹤0.01%	850

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gotham Asset Management's CCXI Position: Q1 2020 in Review

Gotham Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2020, closing a stake of 13,636 shares — an estimated $539K sold.

Gotham Asset Management first reported a position in CCXI in Q2 2018 and held it in 2 quarters. The position peaked at $539K in Q4 2019. 162 funds tracked by Wall St. Rank hold CCXI as of Q1 2020.

Gotham Asset Management reported no remaining ChemoCentryx, Inc. position as of Q1 2020 after selling out during the quarter.
Gotham Asset Management sold 13,636 ChemoCentryx, Inc. shares in Q1 2020, an estimated $539K.
Gotham Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 2 quarters.
Gotham Asset Management's ChemoCentryx, Inc. position peaked at $539K in Q4 2019.
162 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2020.

Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.